Review Article


Seizure-Control Effect of Levatiracetam on Juvenile Myoclonic Epilepsy and Other Epileptic Syndromes: Literature Review of Recent Studies

Arsalan HASHEMIAGHDAM, Amirsina SHARIFI, Mojtaba MIRI, Abbas TAFAKHORI

Iranian Journal of Child Neurology, Vol. 9 No. 2 (2015), , Page 1-8
https://doi.org/10.22037/ijcn.v9i2.6920

How to Cite This Article: Hashemiaghdam A, Sharifi A, Miri M, Tafakhori A. Seizure-Control Effect of Levatiracetam on Juvenile Myoclonic Epilepsy and Other Epileptic Syndromes: Literature Review of Recent Studies. Iran J Child Neurol. Spring 2015;9(2):1-8.

Abstract
Objective
Various epileptic syndromes may present in adolescence and Juvenile Myoclonic Epilepsy (JME) is known to be the most common idiopathic generalized epileptic syndrome presenting itself with different types of seizure activity. The exact etiology of JME is still unknown, but hypoxia, storage disease, toxic-metabolic disorders, drug reactions, and neurodegenerative disorders have been revealed to cause disease manifestation. Previous research shows that JME includes 5–10% of all cases diagnosed with epilepsy. It is estimated to include 18% of idiopathic generalized epilepsies. Females are at higher risk of developing this condition. Levatiracetam (LEV) is an anti-epileptic drug that has become one of the most used drugs for the management of epileptic syndromes. It has less drug interactions, milder side effects, and broad-spectrum efficacy to make it an ideal drug to control seizures. Different mechanisms of actions have made LEV a novel anti-epileptic drug. This new medication can be used as a mono- or add-on therapy to previous anti-epileptic drugs. One of the clinically valuable pharmacological aspects of LEV is that it can be started at a high therapeutic dosage and is well tolerated. The median starting dosage varied according to patients underlying disease, age, and disease severity. We have also discussed the effect of LEV on other epileptic syndromes, which showed promising results in both adults and children. In childhood epilepsy, there is evidence proving that a higher rate of behavioral disturbances with neurological disorders can be improved by LEV therapy. Finally, our review showed the beneficial effects of LEV on seizure-control in different epileptic syndromes especially as a monotherapy.

Research Article


How to Cite This Article: Wilson MD. Animal Models of Cerebral Palsy: Hypoxic Brain Injury in the Newborn. Iran J Child Neurol. Spring
2015; 9(2):9-16.

Abstract

Objective

Hypoxic insults are implicated in the spectrum of fetal disorders, including cerebral palsy (CP). In view of the major contribution of intrapartum risk factors and prematurity to subsequent neurological morbidity and mortality in humans, this study aimed to clarify the pathophysiology of brain injury, especially periventricular white matter damage (WMD), that occur in utero to the immature and near-term fetal CNS.

Materials & Methods

An evaluation of the resulting neurological and behavioural phenotype in the newborn was performed by utilising a battery of neurobehavioural tests, including the Morris water-maze and the open-field test, followed by cerebral MRI and histopathology.

Results

This study used a murine model to examine the deleterious effects of WMD brought about by cerebral hypoxia-ischemia (HI) and the characteristic features of CP in mice. Murine models have proven themselves valuable in the area of experimental neuroscience.

Conclusion

Hypoxia-treated mice were observed to demonstrate a significant neurofunctional deficit compared with sham mice on two behavioral measures. Indeed, different brain regions, including the sensorimotor cortex, the striatum, and the hippocampus were noticeably damaged after HI insult, as determined by both MRI and histopathology. These results, albeit qualitative in nature, appear to support the pre-existing finding that the long-term neurofunctional outcome in animal subjects with CP is strongly associated with the anatomical extent and pattern of cerebral damage as determined by both delayed neuroimaging and histopathology.

Comparison of the Efficacy of Combination Therapy of Prednisolone-Acyclovir with Prednisolone Alone in Bell’s Palsy

Ali KHAJEH, Afshin FAYYAZI, Gholamreza SOLEIMANI, Ghasem MIRI-ALIABAD, Sara SHAYKH VEISI, Behrouz KHAJEH

Iranian Journal of Child Neurology, Vol. 9 No. 2 (2015), , Page 17-20
https://doi.org/10.22037/ijcn.v9i2.5838

How to Cite This Article: Khajeh A, Fayyazi A, Soleimani Gh, Miri-Aliabad Gh, Shaykh Veisi S, Khajeh B. Comparison of the Efficacy of
Combination Therapy of Prednisolone-Acyclovir with Prednisolone Alone in Bell’s Palsy. Iran J Child Neurol. Spring 2015; 9(2):17-20.

Abstract

Objective

Bell’s palsy is a rapid onset, usually, unilateral paralysis of the facial nerve that causes significant changes in an individual’s life such as a decline in personal, social, and educational performance. This study compared efficacy of combined prednisolone and acyclovir therapy with prednisolone alone.

Materials & Methods

This study is a randomized controlled trial conducted on 43 Children (2–18 years old) with Bell’s palsy. The first group of 23 patients was treated with prednisolone and the remaining patients were treated with a combination of prednisolone and acyclovir. The required data were extracted, using an informational form based on the House-Brackmann Scale, which grades facial nerve paralysis. The data were analyzed with Mann-Whitney test using SPSS version 16.

Results

The mean age of the first and second group were 8.65 ± 5.07 and 8.35 ± 4.92 years, respectively, (p=0.84). Sixty one percent and 39% of patients in the first group, and 45% and 55% of patients in the second group were male and female, respectively. No significant differences exist between the groups in terms of age and gender. The rate of complete recovery was 65.2% in group I and 90% in the group II (p=0.04).

Conclusion

The results of this study showed that the combined prednisolone and acyclovir therapy of patients with Bell’s palsy is far more effective than treatment with prednisolone alone. Actually, age and gender had no impact on the rate of recovery.

Brainstem Auditory Evoked Potentials in Boys with Autism: Still Searching for the Hidden Truth

Athina VERVERI, Euthymia VARGIAMI, Vassiliki PAPADOPOULOU, Dimitrios TRYFONAS, Dimitrios I ZAFEIRIOU

Iranian Journal of Child Neurology, Vol. 9 No. 2 (2015), , Page 21-28
https://doi.org/10.22037/ijcn.v9i2.6225

How to Cite This Article: Ververi A, Vargiami E, V Papadopoulou V, Tryfonas D, Zafeiriou DI. Brainstem Auditory Evoked Potentials in
Boys with Autism: Still Searching for the Hidden Truth. Iran J Child Neurol. Spring 2015;9(2):21-28.

Abstract
Objective

Brainstem auditory evoked potentials (BAEPs) have long been utilized in the investigation of auditory modulation and, more specifically, auditory brainstem functions in individuals with autism. Although most investigators have reported
significant abnormalities, no single BAEPs pattern has yet been identified. The present study further delineates the BAEPs deficits among subjects with autism.
Materials & Methods
BAEPs were recorded in 43 male patients, aged 35–104 months, who underwent standard evaluations after receiving a diagnosis of autism. The control group consisted of 43 age-matched typically developing boys. The study took place in
a tertiary neurodevelopmental center over a period of two years.
Results
The mean values of all absolute and/or interpeak latencies were longer in patients when compared to controls, albeit the differences were not significant for any of the parameters. Prolonged or shortened absolute/interpeak latencies (control group mean ± 2.5SD) were unilaterally or bilaterally identified in 33% of patients, compared to 9% of controls. The most frequent findings included prolongation of absolute latencies I, V and III, followed by shortening of interpeak latency I-V. In addition, abnormalities (either shortening or prolongation) of absolute latencies I and V, as well as interpeak latency I-V, were significantly more common among patients. Taken together, BAEPs in 23% of patients were indicative of a clinically abnormal response in 32% of patients.
Conclusion
As can be easily concluded, BAEPs abnormalities characterize only a subset of subjects with autism, who may be important to identify clinically. The latter individuals may benefit from targeted intervention to utilize brainstem plasticity.

The Etiology and Clinical Evaluations of Neonatal Seizures in Kashan, IRAN

Ahmad TALEBIAN, Mohammad JAHANGIRI, Mahin Rabiee RABIEE, Negin MASOUDI ALAVI, Hossein Akbari AKBARI, Zohreh SADAT

Iranian Journal of Child Neurology, Vol. 9 No. 2 (2015), , Page 29-35
https://doi.org/10.22037/ijcn.v9i2.6248

How to Cite This Article: Talebian A, Jahangiri M, Rabiee M, Masoudi Alavi N, Akbari H, Sadat Z. The Etiology and Clinical Evaluations of
Neonatal Seizures in Kashan, IRAN. Iran J Child Neurol. Spring 2015;9(2):29-41.

 

Abstract

Objective

Detection of seizure, its etiology, and clinical types is important for guiding therapy. This study was designed to evaluate the etiology and clinical evaluations of neonatal seizures in Kashan, Iran.

Materials and Methods

The data of 100 hospitalized neonates with a complaint of seizures in Kashan City, from January 2006 to January 2011 were evaluated. The pediatric neurologist made the final diagnosis. The gestational age, neonate admission age, type of delivery, and laboratory and radiological investigations were reviewed   from the medical records. The relation of seizure etiology and other variables were compared using the Chi-square test. All the statistical analyses were performed using SPSS (ver 11.5).

Results

A total of 100 neonates were hospitalized with a diagnosis of seizures. The overall incidence rate of seizures was 2.6 per 1,000 live births. A total of 59% of seizures happened in the first three days of life. The etiologies of seizures were hypoxicischemic encephalopathy (HIE) (36%), hyponatremia (12%), hypoglycemia (11%), intracranial hemorrhage (11%), infections (10%), hypocalcemia (8%), metabolic disorders (7%), the structural anomalies (5%), and hypomagnesaemia (4%). In 23% of neonates, no specific etiology was found and 23% had multiple etiologies. In 45% of neonates, the EEG was not recorded. The type of the seizures were focal-clonic (26%), tonic (25%), multifocal clonic (34%), subtle

(11%), and myoclonic (4%). The types of the seizure were unrelated to the paraclinical findings.

Conclusion

Neonatal seizures are common and HIE was the main cause of seizures in this study. The clinical evaluation of neonatal seizures needs improvement.

Effects of Neurodevelopmental Therapy on Gross Motor Function in Children with Cerebral Palsy

Sina LABAF, Alireza SHAMSODDINI, Mohammad Taghi HOLLISAZ, Vahid Sobhani SOBHANI, Abolfazl SHAKIBAEE

Iranian Journal of Child Neurology, Vol. 9 No. 2 (2015), , Page 36-41
https://doi.org/10.22037/ijcn.v9i2.6165

How to Cite This Article: labaf S, Shamsoddini A, Hollisaz MT, Sobhani V, Shakibaee A . Effects of Neurodevelopmental Therapy on Gross Motor Function in Children with Cerebral Palsy. Iran J Child Neurol. Spring 2015;9(1):37-42.

Abstract

Objective

Neurodevelopmental treatments are an advanced therapeutic approach practiced by experienced occupational therapists for the rehabilitation of children with cerebral palsy. The primary challenge in children with cerebral palsy is gross motor dysfunction. We studied the effects of neurodevelopmental therapy on gross motor function in children with cerebral palsy.

Materials & Methods

In a quasi-experimental design, 28 children with cerebral palsy were randomly divided into two groups. Neurodevelopmental therapy was given to a first group (n=15) with a mean age of 4.9 years; and a second group with a mean age 4.4 years (n=13) who were the control group. All children were evaluated with the Gross Motor Function Measure. Treatments were scheduled for three - one-hour sessions per week for 3 months.

Results

We obtained statistically significant differences in the values between the baseline and post treatment in two groups. The groups were significantly different in laying and rolling (P=0.000), sitting (0.002), crawling and kneeling (0.004), and standing abilities (P=0.005). However, there were no significant

differences in walking, running, and jumping abilities between the two groups (0.090).

Conclusion

We concluded that the neurodevelopmental treatment improved gross motor function in children with cerebral palsy in four dimensions (laying and rolling, sitting, crawling and kneeling, and standing). However, walking, running, and jumping did not improve significantly.

How to Cite This Article: Bilan N, Ganji Sh. Comparison of CPAP with Humidifie, Blender, and T-piece on the Outcome of Weaning in Patients with Neurological Disorders. Iran J Child Neurol. Spring 2015;9(2):42-45.

 

Abstract

Objective

 The procedure for weaning from mechanical ventilation in many patients is a difficult and long process and increases the time of mechanical ventilation. There are numerous ways to achieve weaning. One common method is the use of CPAP. Considering the lower price of a humidifier, blender, and T-piece compared with CPAP and in light of the limited number of studies in this field the current study purposed to compare these two procedures.

Materials & Methods

Fifty-one patients with neurological disorders who were under mechanical ventilation and ready to wean were allocated randomly into two groups: the CPAP group and the humidifier, blender, and T-piece group. Duration of hospital and PICU stay, number of days under mechanical ventilation, frequency of re-intubation, and mortality rate among patients were documented.

Results

The patients were 33 males and 18 females (64.7% and 35.3%, respectively) with an average age of 22.5 ± 4.5 months.

The main indication for intubation was impending respiratory failure.

Hospital stay was 22±15 and 21±13 days for the humidifier and CPAP groups, respectively.

PICU stay was 13±11 and 21±13 days for the humidifier and CPAP groups, respectively. Re-intubation rates were 17.2% and 45.5% for the humidifier and CPAP groups, respectively.

Mortality rates were 3.4% and 22.5% for the humidifier and CPAP groups, respectively.

Conclusion

Considering no statistically significant difference between the two groups, using the humidifier, blender, and T-piece is recommended.

 

The Role of Antiepileptic Treatment in the Recurrence Rate of Seizures After First Attack: A Randomized Clinical Trial

Farhad ASSARZADEGAN, Hanif TABESH, Omid HESAMI, Hojjat DERAKHSHANFAR, Nahid BELADI MOGHADAM, Arya SHOGHLI, Andrew David BEALE, Seyed-Mostafa HOSSEINI-ZIJOUD

Iranian Journal of Child Neurology, Vol. 9 No. 2 (2015), , Page 46-52
https://doi.org/10.22037/ijcn.v9i2.4830

How to Cite This Article: Assarzadegan F, Tabesh H, Hesami O, Derakhshanfar H, Beladi Moghadam N, Shoghli A, Beale A.D, Hosseini-
Zijoud S.M. The Role of Antiepileptic Treatment in the Recurrence Rate of Seizures After First Attack: A Randomized Clinical Trial. Iran J
Child Neurol. Spring 2015; 9(2):46-52.

Abstract

Objective

Epilepsy is a serious, potentially life-shortening brain disorder that occurs in patients of all ages and races. A total of 2–4% of people have experienced seizures at least once in their lifetime. Although treatment usually begins after a seizure, it is an important question whether the first cases of seizure do need to be treated by antiepileptic drugs. In this manner, we compare the recurrence rates of epilepsy in first seizure patients treated with sodium valproic acid as an antiepileptic drug versus a placebo.

Material & Methods

In a randomized clinical trial study, 101 first seizure patients were randomly divided into two groups: one group was treated with antiepileptic drugs (sodium valproate 200mg, three times a day) and the other group was given a placebo.

The recurrence rate of seizures was evaluated and compared between the groups after 6 months of follow up.

Results

Eight recurrence cases were detected. All recurrence cases came from the placebo group, with four patients suffering an additional seizure after four months and between 4-6 month follow up. A comparison of recurrence rate detected a statistically significant difference between the drug group and placebo group.

Conclusion

Our data shows that the recurrences occurred only in the placebo group with the difference between the recurrence rates in the placebo versus drug-treated was significant. Our results suggest that drug therapy for people after their first seizure attack might reduce the probability of seizure recurrence.

Neurometabolic Disorder Articles


Homocystinuria: A Rare Disorder Presenting as Cerebral Sinovenous Thrombosis

Hossein ESLAMIYEH, Farah ASHRAFZADEH, Javad AKHONDIAN, Mehran BEIRAGHI TOOSI

Iranian Journal of Child Neurology, Vol. 9 No. 2 (2015), , Page 53-57
https://doi.org/10.22037/ijcn.v9i2.6147

How to Cite This Article: Eslamiyeh H, Ashrafzadeh F, Akhondian J, Beiraghi Toosi M. Homocystinuria: A Rare Disorder Presenting as Cerebral Sinovenous Thrombosis. Iran J Child Neurol. Spring 2015;9(2):53-57.

Abstract

Objective

Homocystinuria is an inborn error of amino acid metabolism caused by cystathionine beta-synthase deficiency that affects methionine metabolism. The clinical features are heterogeneous ranging from mental retardation, ectopia lentis, and osteoporosis to vascular events such as deep vein thrombosis,   sagital sinus thrombosis, and myocardial infarction. Cerebral sinovenous thrombosis (CVST) is an unusual disorder in children and requires prompt and accurate management. Some causal factors for the

development of CVST differ between children and adults. The majority of cases with CSVT are found to have an underlying cause for thrombosis like dehydration, infections, prothrombotic and hematologic disorders, malignancy and trauma.

Although homocystinuria is usually associated with ischemic strokes, CVST as initial clinical presentation of homocystinuria is rare in children.

In this article, we presented a 10-year old boy with seizure, hemiparesis, and ataxia due to CSVT caused by homocystinuria.

Biotinidase Deficiency in Newborns as Respiratory Distress and Tachypnea: A Case Report

Shahin KOOHMANAEE, Marjaneh ZARKESH, Manijeh TABRIZI, Afagh HASSANZADEH RAF, Siamak DIVSHALI, Setila DALILI

Iranian Journal of Child Neurology, Vol. 9 No. 2 (2015), , Page 58-60
https://doi.org/10.22037/ijcn.v9i2.6137

How to Cite This Article: Kohmanaee Sh, Zarkesh M, Tabrizi M, Hassanzadeh Rad A, Divshali S, Dalili S. Biotinidase Deficiency in Newborns as Respiratory Distress and Tachypnea: A Case Report. Iran J Child Neurol. Spring 2015; 9(2):58-60.

Abstract

Objective

Biotin is a coenzyme composed of four carboxylases. It presents in amino acid catabolism, fatty acid synthesis, and gluconeogenesis. Biotinidase recycles the vitamin biotin. A biotinidase deficiency is a neurocutaneous disorder with autosomal recessive inheritance. The symptoms can be successfully treated

or prevented by administering pharmacological doses of biotin. Although, according to neonatal prenatal medicine (2011), a biotinidase deficiency does not manifest during the neonatal period. In this study, we report on a case of biotinidase deficiency in the first week of birth.

Case Report

A 3100 g term boy was born via cesarean section. After 3 days, he was referred to the 17th Shahrivar Hospital with the chief complaint of tachypnea and grunting.

Laboratory results revealed that liver and renal function tests, serum electrolytes, and blood indexes except ammonia were all normal. Within few days after the administration of oral biotin, the patient showed dramatic improvement and was discharged. However, within 4 months he was admitted two other times with the complaints of diarrhea and pneumonia. Unfortunately, he expired after 4 months.

Conclusion

According to our results, it seems that clinicians should accurately assess suspicious patients and even assess infants for biotinidase deficiency.

Case Report


Baclofen Induced Encephalopathy in a 6-Year-Old Boy with Advanced Renal Failure

Majid MALAK, Mohammad BARZEGAR

Iranian Journal of Child Neurology, Vol. 9 No. 2 (2015), , Page 61-63
https://doi.org/10.22037/ijcn.v9i2.6239

How to Cite This Article: Malak M, Barzgar M. Baclofen Induced Encephalopathy in a 6-Year-Old boy with Advanced Renal Failure. Iran J Child Neurol. Spring 2015;9(2):61-63.

 

Abstract

Baclofen is a drug for many diseases for all ages, but it is hazardous in patients with renal failure. This article talks about a case of baclofen overdose in a child with renal failure.

A 6-year-old boy admitted to the emergency department with a loss of consciousness, hypotonia, and areflexia following administration of 20 mg baclofen (1mg/kg/daily) in total dose for his voiding dysfunction. His laboratory tests showed advanced renal failure. After withholding the medication and

supportive therapy, he recovered completely after two days. After arousal, he complained of insomnia, strange sensations on the skin, intentional tremors, and ataxia. He left the hospital in good condition in three days.

Renal function control before baclofen administration is mandatory especially in high-risk groups. A total dose of 1mg/kg lead to encephalopathy in children with advanced renal failure, with subtle persistent complaints persist are often overlooked for a while.

Double Cortex Syndrome (Subcortical Band Heterotopia): A Case Report

Ali Akbar MOMEN, Mehdi MOMEN

Iranian Journal of Child Neurology, Vol. 9 No. 2 (2015), , Page 64-68
https://doi.org/10.22037/ijcn.v9i2.6713

How to Cite This Article: Momen AA. Momen M. Double Cortex Syndrome (Subcortical Band Heterotopia); A Case Report. Iran J Child Neurol. 2015;9(2):64-68.

Abstract

Objective

Approximately 5–10% of preschool age children are considered developmentally disabled. Brain Magnetic Resonance Imaging (MRI) plays a key role in the diagnostic evaluation in these children. Many congenital or acquired brain anomalies are revealed with MRIs. Although the majority of these abnormalities are sporadic but patients with subcortical band heterotopia or double cortex syndrome have sex-linked inheritance. We are going to present the first case in Iran from Ahvaz city, which was presented with status epilepticus associated with developmental delay and finally diagnosed as double cortex syndrome, because band heterotopia cases especially for continuous or generalized form is rare.

A 4.5-year-old developmentally delayed girl was admitted for generalized tonic clonic seizure attack of 1 hr, upward gaze, locked mouth, and urinary incontinence (status epilepticus) in the child neurology ward. She had a history of recurrent seizures that started as febrile seizures since she was 12 months of age and had frequent admissions for having recurrent seizure attacks. She was the only child of consanguineous parents with negative family history of any neurologic problems. She was a product of uneventful term pregnancy, vaginal delivery with a low Apgar score at birth who was admitted for six days in the neonatal ward for hypotonia and cyanosis. At 4.5 years of age, she had HC: 45cm (<3%) Length: 102 cm (25–75%), and BW: 18kg (75%).

She was able to sit, walk with support, speak a few words, and communicate with others. A physical exam was unremarkable. Lab data including CBC, blood biochemical, and urinalysis results were all within normal limits, but the electroencephalography (EEG) revealed generalized poly spike-wave discharges. A brain MRI showed corpus callosal dysplasia, generalized band heterotopia, and polymicrogyria. She was discharged home with oral valproate and regular outpatient follow-ups.

In the diagnostic evaluation of developmentally delayed and epileptic children, a brain MRI is strongly recommended for accurate diagnosis of anomalies such as neuronal migration disorders (band heterotopia) and others, because appropriate therapeutic management, prognosis, prevention, and genetic

counseling for prenatal diagnosis are dependent on definite diagnosis of the proband case.